Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 10/20 | 0.50 |
| ▸ | PARP15 | Q460N3 | 3/20 | 0.50 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.50 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.48 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.48 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31371753 | 0.94 | CA12 (0.50) | PARP10PARP15PARP2PARP4ALDH1A1 | |
| Formic Acid SCHEMBL28050738 | 0.92 | PARP10 (0.44) | PARP10PARP15PARP2PARP4ALDH1A1 | |
| Benzamide SCHEMBL28005389 | 0.85 | PARP1 (0.67) | PARP10ALDH1A1PARP1POLBTSHR | |
| SCHEMBL16595892 | 0.82 | CA1 (0.42) | PARP10PARP15PARP2ALDH1A1POLB | |
| SCHEMBL28255744 | 0.80 | PARP10 (0.53) | PARP10PARP15PARP2PARP4ALDH1A1 | |
| SCHEMBL3838955 | 0.80 | SRD5A2 (0.48) | ALDH1A1MAPTCA2CA1CA12 | |
| SCHEMBL13582530 | 0.80 | CES2 (0.48) | CA2CA1CA12CA4CA9 | |
| Terephthalamide SCHEMBL23774 | 0.79 | PARP1 (0.71) | PARP10PARP15PARP2PARP4ALDH1A1 | |
| SCHEMBL4757633 | 0.78 | PARP10 (0.52) | PARP10PARP15PARP2PARP4ALDH1A1 | |
| SCHEMBL40299 | 0.78 | TSHR (0.60) | ALDH1A1TSHRCA2CA1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463156-A | Amphiphilic organic near-infrared thermal activation delayed fluorescence molecule and preparation method and application thereof | 内蒙古大学 | 2025-02-18 | — | — | CN | claimed |
| CN-116375549-A | Method and system for synthesizing amide compound from nitrile compound | 深圳湾实验室 | 2023-07-04 | — | — | CN | claimed |
| US-7009052-B2 | Sulfonamide derivatives | WARNER LAMBERT COMPANY LLC (US) | 2006-03-07 | — | — | US | claimed |
| US-20050004367-A1 | Sulfonamide derivatives | DU DANIEL Y (US) | 2005-01-06 | — | — | US | claimed |
| WO-2025098545-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553080-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2025-05-14 | — | — | EP | disclosed |
| CN-119463156-A | Amphiphilic organic near-infrared thermal activation delayed fluorescence molecule and preparation method and application thereof | 内蒙古大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119463156-A | Amphiphilic organic near-infrared thermal activation delayed fluorescence molecule and preparation method and application thereof | 内蒙古大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-114773301-B | Method for synthesizing furan compounds from terminal alkyne and iodoylide | 南方医科大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-117098750-A | Molecules having pesticidal utility, and intermediates and methods related thereto | 科迪华农业科技有限责任公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116375549-A | Method and system for synthesizing amide compound from nitrile compound | 深圳湾实验室 | 2023-07-04 | — | — | CN | disclosed |
| EP-3625218-B1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| EP-1608643-A1 | 6-SULFONAMIDE QUINOLINE AND CHROMENE DERIVATIVE AS ANDROGEN RECEPTOR ANTAGONISTS | Warner-Lambert Company LLC (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20050004367-A1 | Sulfonamide derivatives | DU DANIEL Y (US) | 2005-01-06 | — | — | US | disclosed |
| US-20040229955-A1 | intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, | UNIVERSITY OF WASHINGTON | 2004-11-18 | — | — | US | disclosed |
| WO-2004083204-A1 | 6-SULFONAMIDE QUINOLINE AND CHROMENE DERIVATIVE AS ANDROGEN RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-09-30 | — | — | WO | disclosed |
| WO-2004062601-A2 | ANTIBACTERIAL AGENTS | CHIRON CORPORATION (US) | 2004-07-29 | — | — | WO | disclosed |
| US-6384235-B2 | BY CYCLIZATION OF ALKYNYLAMINOAROMATIC, POSSIBLY ATTACHED TO CARRIER, IN POLAR APROTIC SOLVENT WITH ALKALI METAL COMPOUND; DRUG SYNTHESIS | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20010037031-A1 | Preparation of substituted indoles | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-01 | — | — | US | disclosed |
| EP-1127874-A2 | Process for the preparation of substituted indoles | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229955-A1 | intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, | PDF, DDOST, MRPL21 | PARP10 2286/4885PARP15 2314/4885PARP2 3219/4885 |
| US-20050004367-A1 | Sulfonamide derivatives | AR, SULT2A1, SHBG | PARP10 836/4885PARP15 904/4885PARP2 2424/4885 |
| US-20010037031-A1 | Preparation of substituted indoles | AHR, CYP2S1, CBR1 | PARP10 2130/4885PARP15 2335/4885PARP2 2173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.